News
Keep up with the latest updates from the Neurofibromatosis community in Western Australia and beyond. Here you’ll find news about events, awareness campaigns, medical advancements, and community stories that highlight the progress and people making a difference.
NF Knowledge Series Webinar:
Gomekli (Mirdametinib), the Latest FDA-Approved Treatment for NF1
Click the button below to watch a webinar about Gomekli (mirdametinib), a newly FDA-approved treatment for Neurofibromatosis Type 1 (NF1). The video briefly explains how the drug shrinks tumors, relieves pain, improves quality of life, lists possible side effects, and highlights the need for long-term treatment.
(News 2)
Describe the item and include any relevant details. Click to edit the text.
(News 3)
Describe the item and include any relevant details. Click to edit the text.